Sysmex India, an in-vitro diagnostic (IVD) company, headquartered in Mumbai, backed by over 250 dedicated skilled professionals spread across India, has already expanded its footprint in the Indian market. It offers a comprehensive range of solutions in the field of clinical laboratory testing, including haematology, haemostasis, urinalysis, clinical chemistry, flow cytometry, life science and scientific services. With its advanced analysers and reagents, it has achieved a strong customer base comprising Government and private hospitals, stand-alone labs, chain labs, blood banks, primary centres, R&D centres, and medical institutes among others. As a total solution provider, the company has a dedicated customer service centre providing comprehensive support to its clients.
Previously, Sysmex India marketed its products in India through its distribution partner, which has now been discontinued.
In pursuit of its ambitious plan for the Indian market, Sysmex India has set up a state-of-the-art reagent manufacturing facility in Baddi, Himachal Pradesh. Additionally, to meet the increasing demand in India, it has made significant investments to build a new plant in Sanand, Ahmedabad, India. This strategic move will ensure a stable supply of products to the Indian market. Notably, the new plant will follow an environmentally sustainable model, featuring high-quality products, high-efficiency manufacturing processes and an advanced zero liquid discharge system to eliminate water discharge outside the factory site.
Anil Prabhakaran, Managing Director, Sysmex India, reiterated the company’s commitment to the Indian healthcare industry, he stated, “Sysmex is dedicated to scaling up diagnostics for a better healthcare journey. We are committed to delivering quality products, backed by Japanese cutting-edge technology, and unmatched service. With a clear roadmap and robust strategy, Sysmex India aims to establish itself as the market leader in India.”